Lineage Cell Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Lineage Cell Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2015 to Q2 2024.
  • Lineage Cell Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.03 USD/shares, unchanged year-over-year.
  • Lineage Cell Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -0.14 USD/shares, a 7.69% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.12 USD/shares, a 20% increase from 2022.
  • Lineage Cell Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -0.15 USD/shares, a 42.3% increase from 2021.
  • Lineage Cell Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -0.26 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0 $0 $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $0 $0 $0 -33.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $0 $0 $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $0 $0 $0 0% Jul 1, 2023 Sep 30, 2023 10-K 2024-03-07
Q2 2023 $0 $0 +$0.01 +25% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $0 $0 +$0.01 +25% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $0 $0 +$0.14 +82.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $0 $0 +$0.01 +20% Jul 1, 2022 Sep 30, 2022 10-K 2024-03-07
Q2 2022 $0 $0 $0 -33.3% Apr 1, 2022 Jun 30, 2022 10-K 2024-03-07
Q1 2022 $0 $0 $0 -300% Jan 1, 2022 Mar 31, 2022 10-K 2024-03-07
Q4 2021 $0 $0 $0 -1800% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $0 $0 $0 0% Jul 1, 2021 Sep 30, 2021 10-K 2023-03-09
Q2 2021 $0 $0 +$0.01 +25% Apr 1, 2021 Jun 30, 2021 10-K 2023-03-09
Q1 2021 $0 $0 +$0.05 +83.3% Jan 1, 2021 Mar 31, 2021 10-K 2023-03-09
Q4 2020 $0 $0.01 +$0.04 Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $0 $0 +$0.06 +54.5% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-10
Q2 2020 $0 $0 +$0.16 +80% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-10
Q1 2020 $0 $0 $0 -120% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-10
Q4 2019 $0 $0 +$0.33 +91.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $0 $0 -$1 -121% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 $0.27 $0 $0 -567% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 $0.44 $0.30 +$0.80 Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 $0 $0 +$0.22 +37.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$1 $0.53 +$0.41 +342% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$1 $0 +$0.08 +72.7% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$1 $1 -$1 -209% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 $0 -$1 -$1 -1060% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 $0.42 $0.12 $0 -60% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 $0.60 $0 $0 -142% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 $0.97 $0.46 +$0.65 Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
Q4 2016 $0.32 $0 Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 $0.30 +$0.48 Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 $0.26 +$0.38 Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 $0 Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
Q3 2015 $0 Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.